199 related articles for article (PubMed ID: 35504188)
1. Activated microglia by
Wang J; Jin L; Zhang X; Yu H; Ge J; Deng B; Li M; Zuo C; Chen X
J Neuroimmunol; 2022 Jul; 368():577879. PubMed ID: 35504188
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Superiority of 18 F-FDG PET Over MRI in Detecting Anti-LGI1 Autoimmune Encephalitis : A Comparative Study With Insights Into Faciobrachial Dystonic Seizures Mechanisms and Recurrence Identification.
Liang M; Niu N; Jia C; Fan S; Liu L; Cui R; Guan H
Clin Nucl Med; 2023 Nov; 48(11):e516-e522. PubMed ID: 37703438
[TBL] [Abstract][Full Text] [Related]
3. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC
Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863
[TBL] [Abstract][Full Text] [Related]
4. Anti-LGI1 Autoimmune Epilepsy.
Burkett BJ; Johnson DR; Hunt CH; Messina SA; Broski SM
Clin Nucl Med; 2023 Nov; 48(11):956-957. PubMed ID: 37703448
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.
Celicanin M; Blaabjerg M; Maersk-Moller C; Beniczky S; Marner L; Thomsen C; Bach FW; Kondziella D; Andersen H; Somnier F; Illes Z; Pinborg LH
Eur J Neurol; 2017 Aug; 24(8):999-1005. PubMed ID: 28544133
[TBL] [Abstract][Full Text] [Related]
6. A rare case of anti-LGI1 limbic encephalitis with concomitant positive NMDAR antibodies.
Ji T; Huang Z; Lian Y; Wang C; Zhang Q; Li J
BMC Neurol; 2020 Sep; 20(1):336. PubMed ID: 32894089
[TBL] [Abstract][Full Text] [Related]
7. Characterization of neuroinflammation pattern in anti-LGI1 encephalitis based on TSPO PET and symptom clustering analysis.
Wang J; Ge J; Jin L; Deng B; Tang W; Yu H; Zhang X; Liu X; Xue L; Zuo C; Chen X
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2394-2408. PubMed ID: 36929211
[TBL] [Abstract][Full Text] [Related]
8. Bi-Basal Ganglia Involvement with Signal Evolution in a Case of Anti-LGI1 Encephalitis.
Gai Q; Ruan S; Dong X; Cong S
Neurol India; 2022; 70(1):384-386. PubMed ID: 35263922
[TBL] [Abstract][Full Text] [Related]
9. Agrypnia excitata as the main feature in anti-leucine-rich glioma-inactivated 1 encephalitis: a detailed clinical and polysomnographic semiological analysis.
Piffer S; Cantalupo G; Filipponi S; Poretto V; Pellegrini M; Tanel R; Buganza M; Giometto B
Eur J Neurol; 2022 Mar; 29(3):890-894. PubMed ID: 34679240
[TBL] [Abstract][Full Text] [Related]
10. Anti-leucine-rich Glioma Inactivated-1 Encephalitis Associated with Essential Thrombocythemia.
Yuan X; Man X; Zhang J; Sun J; Liang J; Ma H; Tao S; Guo D; Liu L
Intern Med; 2020; 59(2):271-275. PubMed ID: 31941873
[TBL] [Abstract][Full Text] [Related]
11. [Ictal electroencephalography (EEG) activity and cerebral blood flow dynamics as potential pathological indicators: a case of anti-leucine-rich glioma-inactivated 1 protein (LGI1) encephalitis].
Ishibashi H; Neshige S; Aoki S; Ueno H; Iida K; Maruyama H
Rinsho Shinkeigaku; 2020 Nov; 60(11):778-785. PubMed ID: 33115994
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune encephalitis related to LGI1 antibodies with negative MRI study: Description of two cases.
Lian X; Zheng K; Chen W; Li D; Xue F; Wang G
Med Clin (Barc); 2024 Jan; 162(1):35-38. PubMed ID: 37517931
[TBL] [Abstract][Full Text] [Related]
13. Persistent hiccup as one of the initial symptoms of leucine-rich glioma-inactivated-1 encephalitis: a case report.
Hou L; Wan L; Li H; Wang Z; Guan H; Ren H; Wang P
BMC Neurol; 2022 Jul; 22(1):281. PubMed ID: 35896991
[TBL] [Abstract][Full Text] [Related]
14. Anti-leucine-rich glioma-inactivated 1 encephalitis: two case reports and a review of the literature.
Karvigh SA; Salehizadeh S; Vahabizad F
J Med Case Rep; 2022 Nov; 16(1):409. PubMed ID: 36348436
[TBL] [Abstract][Full Text] [Related]
15. Anti-LGI1 encephalitis recurring 3 years after the first episode: a case report.
Fujita H; Shioda M; Suzuki K
BMC Neurol; 2022 Apr; 22(1):148. PubMed ID: 35448972
[TBL] [Abstract][Full Text] [Related]
16. Subcortical Hypermetabolism Associated With Cortical Hypometabolism Is a Common Metabolic Pattern in Patients With Anti-Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis.
Zhao X; Zhao S; Chen Y; Zhang Z; Li X; Liu X; Lv R; Wang Q; Ai L
Front Immunol; 2021; 12():672846. PubMed ID: 34616389
[TBL] [Abstract][Full Text] [Related]
17. CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis.
Li J; Li H; Wang Y; Zhao X; Wang S; Li L
Front Immunol; 2022; 13():1071219. PubMed ID: 36685530
[TBL] [Abstract][Full Text] [Related]
18. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
Huang X; Fan C; Gao L; Li L; Ye J; Shen H
J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327
[TBL] [Abstract][Full Text] [Related]
19. Anti-LGI1 encephalitis: A family affair.
De Stefano G; Pulitano P; Di Bonaventura C; Zuliani L; Morano A
J Neuroimmunol; 2023 May; 378():578084. PubMed ID: 37037125
[TBL] [Abstract][Full Text] [Related]
20. When should we test patients with epilepsy for autoimmune antibodies? Results from a French retrospective single center study.
Kambadja B; Marion H; Cousyn L; Mezouar N; Navarro V; Herlin B; Sophie D
J Neurol; 2022 Jun; 269(6):3109-3118. PubMed ID: 34816332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
